Market Overview

UPDATE: Morgan Stanley Downgrades CIT Group to Equal-Weight on Fewer Catalysts Outstanding

Share:
Related CIT
Benzinga's Top Upgrades, Downgrades For March 27, 2017
Benzinga's Option Alert Recap From March 21

Morgan Stanley downgraded CIT Group (NYSE: CIT) from Overweight to Equal-weight and maintained a $46.00 price target.

Morgan Stanley said, "Risk-reward skew looks more balanced; we see fewer NT catalysts to drive CIT meaningfully higher. CIT shares are up 18% from lows post 3Q12 earnings as the company has achieved several key milestones to achieving their long-term targets, most importantly the elimination of more than $15B of high-cost debt and growing deposits to 31% of funding. Next catalysts for the stock include approval of CIT's capital plan, removal of the written agreement, and potential acquisitions (as indicated by mangement)."

CIT Group closed at $42.71 on Wednesday.

Latest Ratings for CIT

DateFirmActionFromTo
Mar 2017Morgan StanleyInitiates Coverage OnEqual-Weight
Nov 2016BMO CapitalDowngradesMarket PerformUnderperform
Nov 2016Stephens & Co.Initiates Coverage OnEqual-Weight

View More Analyst Ratings for CIT
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Downgrades Analyst Ratings

 

Related Articles (CIT)

View Comments and Join the Discussion!